CIBC World Market
MYGN icon

CIBC World Market’s Myriad Genetics MYGN Stock Holding History

CIBC World Market’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,369
Closed -$257K – 1412
2024
Q3 		$257K Buy
+9,369
New +$254K ﹤0.01% 1178
2019
Q1 		– Sell
-7,106
Closed -$207K – 1199
2018
Q4 		$207K Sell
7,106
-1,258
-15% -$45.3K ﹤0.01% 1002
2018
Q3 		$385K Sell
8,364
-2,852
-25% -$127K ﹤0.01% 909
2018
Q2 		$419K Sell
11,216
-12,544
-53% -$424K ﹤0.01% 885
2018
Q1 		$702K Buy
23,760
+16,263
+217% +$550K ﹤0.01% 746
2017
Q4 		$257K Buy
7,497
+62
+0.8% +$2.09K ﹤0.01% 695
2017
Q3 		$269K Sell
7,435
-27,971
-79% -$798K ﹤0.01% 661
2017
Q2 		$915K Buy
+35,406
New +$752K ﹤0.01% 679
2014
Q1 		– Sell
-9,890
Closed -$207K – 722
2013
Q4 		$207K Buy
+9,890
New +$250K ﹤0.01% 639

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

CIBC World Market's MYGN Position: Q4 2024 in Review

CIBC World Market sold out of Myriad Genetics (MYGN) in Q4 2024, closing a stake of 9,369 shares — an estimated $257K sold.

CIBC World Market first reported a position in MYGN in Q4 2013 and held it in 9 quarters. The position peaked at $915K in Q2 2017. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2024.

  • CIBC World Market reported no remaining Myriad Genetics position as of Q4 2024 after selling out during the quarter.
  • CIBC World Market sold 9,369 Myriad Genetics shares in Q4 2024, an estimated $257K.
  • CIBC World Market first reported a position in Myriad Genetics in Q4 2013 and held it in 9 quarters.
  • CIBC World Market's Myriad Genetics position peaked at $915K in Q2 2017.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2024.

Based on CIBC World Market's 13F filing for Q4 2024, filed 23 Jan 2025.